Compass Therapeutics CMPX
NASDAQ CMPX
$1.04 -0.06 (-5.45%)
At close: Sep 30, 2026 · 4:00 PM EDT

Compass Therapeutics (CMPX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Compass Therapeutics' Depreciation & Amortization (CF) came in at $21,000 for Q2 2026, down 79.0% from $100,000 a year earlier but up 40.0% from the prior quarter.

Analysis

Compass Therapeutics (CMPX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Compass Therapeutics reported Depreciation & Amortization (CF) of $72,000, down 86.2% year-over-year; for FY2025, it was $276,000, down 53.1% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, with a five-year compound annual growth rate of -35.1% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $589,000 in FY2024 (-15.7%), $699,000 in FY2023 (-10.6%), $782,000 in FY2022 (+38.2%) and $566,000 in FY2021 (-76.5%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $15,000 (Q1 2026) to $220,000 (Q2 2022).
  • Year-over-year, Depreciation & Amortization (CF) has declined for 13 consecutive quarters, with an average decline of 51.5% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2022 (growth of 57.3%), and the weakest in Q1 2026 (a decline of 89.3%).
  • Business Quant data shows CMPX's Depreciation & Amortization (CF) at $15,000 (Q1 2026), $17,000 (Q4 2025) and $19,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Compass Therapeutics 187.29 Mn 187.29 Mn - 21,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21,000.00
Mar 31, 2026 15,000.00
Dec 31, 2025 17,000.00
Sep 30, 2025 19,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 140,000.00
Dec 31, 2024 140,000.00
Sep 30, 2024 143,000.00
Jun 30, 2024 152,000.00
Mar 31, 2024 154,000.00
Dec 31, 2023 161,000.00
Sep 30, 2023 164,000.00
Jun 30, 2023 180,000.00
Mar 31, 2023 194,000.00
Dec 31, 2022 195,000.00
Sep 30, 2022 202,000.00
Jun 30, 2022 220,000.00
Mar 31, 2022 165,000.00
Dec 31, 2021 124,000.00
Sep 30, 2021 138,000.00
API Access

Compass Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CMPX&period=max&api_key=YOUR_API_KEY